Navigation Links
Thoratec Reports 34 Percent Increase in 2008 Revenues
Date:2/5/2009

PLEASANTON, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today said that revenues for fiscal 2008 increased 34 percent over revenues in fiscal 2007.

For the year ended January 3, 2009, Thoratec reported revenues of $313.6 million compared with revenues of $234.8 million in fiscal 2007. Revenues for the fourth quarter of fiscal 2008 were $85.7 million, a 34 percent increase over revenues of $64.1 million in the same period a year ago.

Net income on a GAAP basis in fiscal 2008 was $22.5 million, or $0.39 per diluted share, versus GAAP net income of $3.2 million, or $0.06 per diluted share, in fiscal 2007. Non-GAAP net income, which is described later in this press release, was $36.9 million, or $0.61 per diluted share, in fiscal 2008 compared with $18.6 million, or $0.33 per diluted share, in fiscal 2007.

"This has been a truly extraordinary year for Thoratec, highlighted by the successful U.S. commercial launch of our HeartMate II(R) LVAS (Left Ventricular Assist System) for bridge-to-transplantation (BTT) and the resultant growth in revenues and earnings," noted Gary F. Burbach, president and chief executive officer.

"Our financial performance in 2008 was driven by an increase in Cardiovascular Division revenues of 49 percent year-over-year. We continue to see positive clinical results with the HeartMate II and better than expected adoption of the device by new centers. This demonstrates the effectiveness of our roll-out strategy designed to ensure that centers have the training and clinical support necessary to achieve successful patient outcomes."

The company said it added 12 new HeartMate II centers during the fourth quart
'/>"/>

SOURCE Thoratec Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. Thoratec Schedules Third Quarter Conference Call, Webcast
2. Thoratecs ITC Division Receives FDA Warning Letter
3. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
4. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
5. Thoratec Schedules First Quarter 2008 Conference Call, Webcast
6. Thoratec Schedules Second Quarter 2008 Conference Call, Webcast
7. Thoratec Reports 44 Percent Increase in Second Quarter Revenues;
8. Thoratec Presentation at Piper Jaffary Conference to be Webcast
9. Thoratec Schedules Fiscal 2008 Year-End Conference Call, Webcast
10. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
11. Haemacure Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014 Presently, disposable medical ... healthcare equipment and supplies segment. During the past two ... steady growth (on an average 12.5% per year), primarily ... settings. Currently, the US is the largest market for ... share of 40%. The second position is held by ...
(Date:7/11/2014)... -- Researchers from The Miriam Hospital have found ... have significantly higher rates of smoking than those ... were less likely to attempt quitting than those ... not be sufficient for this population. The study ... of print in the American Journal of ...
(Date:7/11/2014)... PULLMAN, Wash.The largest study of its kind has ... suite of advantages over their conventional counterparts, including ... , The study looked at an unprecedented 343 ... of organic and conventional plant-based foods, including fruits, ... meta-analysis techniques to quantify differences between organic and ...
(Date:7/11/2014)... FRIDAY, July 11, 2014 (HealthDay News) -- Delaying surgery to ... main ligament in the middle of the knee -- could ... They analyzed the medical records of 130 patients, aged ... patients, 62 had surgery less than six weeks after their ... the others had surgery more than three months after their ...
(Date:7/11/2014)... 11, 2014 (HealthDay News) -- Prostate cancer patients are ... less effective treatment and die sooner if they also ... data from more than 41,200 American men who were ... They followed them through 2009. Nearly 1,900 of the ... years before their prostate cancer was discovered. "Men ...
Breaking Medicine News(10 mins):Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 2Health News:Global Disposable Medical Supplies Market to See Robust Growth Through Next Decade, According to New TriMark Report Available at MarketPublishers.com 3Health News:Miriam Hospital study examines smoking prevalence 2Health News:Major study documents nutritional and food safety benefits of organic farming 2Health News:Major study documents nutritional and food safety benefits of organic farming 3Health News:Delaying Kid's Knee Surgery Could Be a Bad Play, Study Finds 2Health News:Depression May Make It Harder to Beat Prostate Cancer 2
... BOSTON--A surprise discovery -- that calorie-burning brown fat can be ... the prospect of new ways to fight obesity and overweight, ... Aug. 21 issue of the journal Nature, the ... "good" form of fat -- so called because it burns ...
... of new ways to treat obesity , , WEDNESDAY, Aug. ... also helps promote development of "good" brown fat that helps ... researchers at the Joslin Diabetes Center in Boston. , They ... lead to new ways to prevent and treat obesity. , ...
... Aug. 20 Digital health technologies designed to,monitor ... in U.S. revenues in,excess of $1.8 billion by ... in service and hardware,revenues, according to Parks Associates, ... medical, activity, and environmental,sensors and fitness measurement devices ...
... Aug. 20 Cord Blood America, Inc.,(OTC Bulletin ... preservation,company ( http://www.cordblood-america.com ) focused on bringing the ... and internationally,today reported that revenues for the first ... million., Revenues were down from the same ...
... fuels rapid growth by partnering with Flexicare Ltd., a ... intubation products]. , ... ... week that it had expanded its product offering of ...
... AggreWell™400 plate is a novel tool for standardizing the generation ... ... Vancouver, British Columbia (PRWEB) August 20, 2008 -- http://www.stemcell.com ... cell separation products and ancillary reagents for stem cell research, ...
Cached Medicine News:Health News:Making 'good' fat from muscle and vice versa 2Health News:Making 'good' fat from muscle and vice versa 3Health News:Bone Growth Protein Also Promotes 'Good' Fat 2Health News:Service and Hardware Revenues Will Contribute $1.8 Billion to the U.S. Eldercare Industry by 2013 2Health News:Cord Blood America Reports Six Month Financial Results 2Health News:ORSupply.com Introduces New Line of Products from Flexicare 2Health News:STEMCELL Technologies Introduces AggreWell™400 for Standardized Embryonic Stem Cell and Induced Pluripotent Stem Cell Research 2
(Date:1/15/2014)... Corporation (the "Company") (NASDAQ: CLSN ) today ... to purchase an aggregate of approximately $15 million of ... offering, led by a dedicated health care fund. ... these investors pursuant to which the Company agreed to ...
(Date:1/15/2014)... 2014 Shire plc (LSE: SHP, NASDAQ: ... Trading (OFT) approval condition to the announced tender offer for all ... As a result of the waiver, the transaction is no ... tender offer on January 24, 2014 following the currently scheduled expiration ...
(Date:1/15/2014)... BreedIT Corp (OTC: BRDT), through its Israeli ... sophisticated agro-breeding solutions for plant breeders and researchers, today ... of directors appointed chemistry and pharmaceutical industry expert Dr. ... the board. From 1975 to 2012, Dr. ...
Breaking Medicine Technology:Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
This is the modular VICTOR2 multilabel counter with the TR-fluorometry, stacker and robot loading options.The addition of a xenon flash lamp brings the time-resolved fluorescence counting mode to th...
Flexible and sensitive fluorescence/luminescence microplate reader for endpoint and kinetic...
The DELFIA Platewash is a general purpose microtitration plate and strip washer especially standardized for use with DELFIA diagnostic kits....
... with a 25-microplate capacity ... and aspiration and dispense ... On-board software for user ... programs. External vacuum pump ...
Medicine Products: